Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $17.37 --0%
Revenue Growth %: +11.8%
Financial Fact:
Revenues: 24.65M
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +11.8%
Financial Fact:
Revenues: 24.65M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q1 EPS of ($0.20), $0.09 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $52.44 million versus the consensus estimate of $42.81 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Morgan Stanley Upgrades CDW Corporation (CDW) to Overweight
- Organon launches two denosumab biosimilars in Canada
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
